These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 355888)
21. [Immunohistochemical arguments in favor of co-localization of neuropeptides in hypothalamo-infundibular neuron systems]. Tramu G; Beauvillain JC; Croix D; Pillez A; Garaud JC Ann Endocrinol (Paris); 1984; 45(3):175-87. PubMed ID: 6151822 [TBL] [Abstract][Full Text] [Related]
22. LHRH immunopositive cells and their projections to the median eminence and organum vasculosum of the lamina terminalis. King JC; Tobet SA; Snavely FL; Arimura AA J Comp Neurol; 1982 Aug; 209(3):287-300. PubMed ID: 6752217 [TBL] [Abstract][Full Text] [Related]
23. Detection of catecholamine and luteinizing hormone-releasing hormone (LH-RH) containing nerve endings in the median eminence and the organon vasculosum laminae terminalis by fluorescence histochemistry and immunohistochemistry on the same microscopic sections. Ibata Y; Watanabe K; Kinoshita H; Kubo S; Sano Y; Sin S; Hashimura E; Imagawa K Neurosci Lett; 1979 Feb; 11(2):181-6. PubMed ID: 379711 [TBL] [Abstract][Full Text] [Related]
24. Fluorescence-immunocytochemistry: simultaneous localization of catecholamines and gonadotropin-releasing hormone. McNeill TH; Sladek JR Science; 1978 Apr; 200(4337):72-4. PubMed ID: 345442 [TBL] [Abstract][Full Text] [Related]
26. Differential effects of hypothalamic deafferentation upon luteinizing hormone-releasing hormone in the median eminence and organum vasculosum of the lamina terminalis. Weiner RI; Pattou E; Kerdelhue B; Kordon C Endocrinology; 1975 Dec; 97(6):1597-600. PubMed ID: 1107018 [TBL] [Abstract][Full Text] [Related]
27. Influence of central catecholamines on LHRH-containing pathways. Fuxe K; Löfström A; Hökfelt T; Ferland L; Andersson K; Agnati L; Eneroth P; Gustafsson JA; Skett P Clin Obstet Gynaecol; 1978 Aug; 5(2):251-69. PubMed ID: 30560 [No Abstract] [Full Text] [Related]
28. Negative feedback effects of progesterone correlated with changes in hypothalamic norepinephrine and dopamine turnover rates, median eminence luteinizing hormone-releasing hormone, and peripheral plasma gonadotropins. Rance N; Wise PM; Barraclough CA Endocrinology; 1981 Jun; 108(6):2194-9. PubMed ID: 6785075 [TBL] [Abstract][Full Text] [Related]
29. Mediation of the short-loop negative feedback of luteinizing hormone (LH) on LH-releasing hormone release by melatonin-induced inhibition of LH release from the pars tuberalis. Nakazawa K; Marubayashi U; McCann SM Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7576-9. PubMed ID: 1881898 [TBL] [Abstract][Full Text] [Related]
30. The actions of prostaglandin E2, naloxone and testosterone on starvation-induced suppression of luteinizing hormone-releasing hormone and luteinizing-hormone secretion. In vitro and in vivo studies. Küderling I; Dorsch G; Warnhoff M; Pirke KM Neuroendocrinology; 1984 Dec; 39(6):530-7. PubMed ID: 6392920 [TBL] [Abstract][Full Text] [Related]
31. Evidence that norepinephrine and epinephrine systems mediate the stimulatory effects of ovarian hormones on luteinizing hormone and luteinizing hormone-releasing hormone. Adler BA; Johnson MD; Lynch CO; Crowley WR Endocrinology; 1983 Oct; 113(4):1431-8. PubMed ID: 6352246 [TBL] [Abstract][Full Text] [Related]
32. The distribution of enkephalin in the mediobasal hypothalamus of the mouse brain: effects of neonatal administration of MSG. Romagnano MA; Chafel TL; Pilcher WH; Joseph SA Brain Res; 1982 Mar; 236(2):497-504. PubMed ID: 7039767 [TBL] [Abstract][Full Text] [Related]
33. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide. Jhamandas K; Sutak M Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736 [TBL] [Abstract][Full Text] [Related]
34. Endogenous opiates block dopamine inhibition of prolactin secretion in vitro. Enjalbert A; Ruberg M; Arancibia S; Priam M; Kordon C Nature; 1979 Aug; 280(5723):595-7. PubMed ID: 223069 [No Abstract] [Full Text] [Related]
35. Evidence for an action of morphine and the enkephalins on sensory nerve endings in the mouse peritoneum. Bentley GA; Newton SH; Starr J Br J Pharmacol; 1981 Jun; 73(2):325-32. PubMed ID: 7236987 [TBL] [Abstract][Full Text] [Related]
36. Acute increase in responsiveness of luteinizing hormone (LH)-releasing hormone nerve terminals to neuropeptide-Y stimulation before the preovulatory LH surge. Besecke LM; Levine JE Endocrinology; 1994 Jul; 135(1):63-6. PubMed ID: 8013392 [TBL] [Abstract][Full Text] [Related]
37. Prostaglandin E2 releases luteinizing hormone-releasing hormone from the female juvenile hypothalamus through a Ca2+-dependent, calmodulin-independent mechanism. Ojeda SR; Urbanski HF; Katz KH; Costa ME Brain Res; 1988 Feb; 441(1-2):339-51. PubMed ID: 2834003 [TBL] [Abstract][Full Text] [Related]
39. Release of immunoreactive luteinising hormone-releasing hormone and thyrotrophin-releasing hormone from hypothalamus. Bennett GW; Edwardson JA; Holland D; Jeffcoate SL; White N Nature; 1975 Sep; 257(5524):323-5. PubMed ID: 808739 [No Abstract] [Full Text] [Related]
40. Endogenous opioid regulation of gonadotropin-releasing hormone release from the human fetal hypothalamus in vitro. Rasmussen DD; Liu JH; Wolf PL; Yen SS J Clin Endocrinol Metab; 1983 Nov; 57(5):881-4. PubMed ID: 6311863 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]